Clinical Trial Update: IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial of an IGFBP-2 vaccine to prevent ovarian cancer progression in patients with serologic evidence of recurrence. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• IGFBP-2 vaccine (IGFBP-2 vaccine)

Snippet

Sponsor: University of Washington | Conditions: Fallopian Tube Carcinoma, Ovarian Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING